vs

Side-by-side financial comparison of CATO CORP (CATO) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

CATO CORP is the larger business by last-quarter revenue ($155.4M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). CATO CORP runs the higher net margin — -3.3% vs -38.1%, a 34.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 6.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -5.7%).

The Cato Corporation is an American retailer of women's fashions and accessories. The company is headquartered in Charlotte, North Carolina. As of January 2016, the company operated 1,372 stores under the names Cato, Cato Plus, It's Fashion, It's Fashion Metro and Versona.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CATO vs PRCT — Head-to-Head

Bigger by revenue
CATO
CATO
1.9× larger
CATO
$155.4M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+13.9% gap
PRCT
20.2%
6.3%
CATO
Higher net margin
CATO
CATO
34.7% more per $
CATO
-3.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-5.7%
CATO

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CATO
CATO
PRCT
PRCT
Revenue
$155.4M
$83.1M
Net Profit
$-5.2M
$-31.6M
Gross Margin
32.7%
64.9%
Operating Margin
-5.3%
-4.1%
Net Margin
-3.3%
-38.1%
Revenue YoY
6.3%
20.2%
Net Profit YoY
65.6%
-27.9%
EPS (diluted)
$-0.28
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CATO
CATO
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$155.4M
$76.4M
Q3 25
$176.5M
$83.3M
Q2 25
$170.2M
$79.2M
Q1 25
$157.9M
$69.2M
Q4 24
$146.2M
$68.2M
Q3 24
$168.6M
$58.4M
Q2 24
$177.1M
$53.4M
Net Profit
CATO
CATO
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-5.2M
$-29.8M
Q3 25
$6.8M
$-21.4M
Q2 25
$3.3M
$-19.6M
Q1 25
$-14.1M
$-24.7M
Q4 24
$-15.1M
$-18.9M
Q3 24
$95.0K
$-21.0M
Q2 24
$11.0M
$-25.6M
Gross Margin
CATO
CATO
PRCT
PRCT
Q1 26
64.9%
Q4 25
32.7%
60.6%
Q3 25
36.8%
64.8%
Q2 25
35.8%
65.4%
Q1 25
29.2%
63.9%
Q4 24
29.6%
64.0%
Q3 24
35.3%
63.2%
Q2 24
36.5%
59.0%
Operating Margin
CATO
CATO
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-5.3%
-40.6%
Q3 25
3.1%
-27.8%
Q2 25
2.0%
-28.0%
Q1 25
-15.2%
-39.7%
Q4 24
-11.6%
-28.9%
Q3 24
-0.4%
-38.4%
Q2 24
3.5%
-50.3%
Net Margin
CATO
CATO
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-3.3%
-39.1%
Q3 25
3.9%
-25.7%
Q2 25
1.9%
-24.7%
Q1 25
-8.9%
-35.8%
Q4 24
-10.3%
-27.6%
Q3 24
0.1%
-35.9%
Q2 24
6.2%
-48.0%
EPS (diluted)
CATO
CATO
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.28
$-0.54
Q3 25
$0.35
$-0.38
Q2 25
$0.17
$-0.35
Q1 25
$-0.73
$-0.45
Q4 24
$-0.79
$-0.34
Q3 24
$0.01
$-0.40
Q2 24
$0.54
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CATO
CATO
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$79.0M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$167.6M
$347.7M
Total Assets
$450.2M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CATO
CATO
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$79.0M
$286.5M
Q3 25
$90.8M
$294.3M
Q2 25
$80.0M
$302.7M
Q1 25
$77.7M
$316.2M
Q4 24
$86.2M
$333.7M
Q3 24
$104.7M
$196.8M
Q2 24
$105.4M
$214.1M
Total Debt
CATO
CATO
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CATO
CATO
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$167.6M
$365.9M
Q3 25
$172.2M
$380.3M
Q2 25
$164.9M
$385.8M
Q1 25
$162.3M
$389.2M
Q4 24
$177.1M
$402.2M
Q3 24
$195.1M
$241.2M
Q2 24
$196.9M
$251.8M
Total Assets
CATO
CATO
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$450.2M
$508.1M
Q3 25
$436.9M
$511.5M
Q2 25
$440.8M
$513.1M
Q1 25
$452.4M
$519.4M
Q4 24
$424.4M
$534.0M
Q3 24
$455.6M
$374.1M
Q2 24
$477.1M
$374.4M
Debt / Equity
CATO
CATO
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CATO
CATO
PRCT
PRCT
Operating Cash FlowLast quarter
$-12.4M
Free Cash FlowOCF − Capex
$-12.9M
FCF MarginFCF / Revenue
-8.3%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CATO
CATO
PRCT
PRCT
Q1 26
Q4 25
$-12.4M
$-10.3M
Q3 25
$11.8M
$-6.6M
Q2 25
$3.9M
$-15.0M
Q1 25
$-6.5M
$-17.0M
Q4 24
$-22.1M
$-32.4M
Q3 24
$3.1M
$-18.8M
Q2 24
$5.7M
$-15.7M
Free Cash Flow
CATO
CATO
PRCT
PRCT
Q1 26
Q4 25
$-12.9M
$-12.2M
Q3 25
$10.4M
$-9.5M
Q2 25
$2.8M
$-17.8M
Q1 25
$-7.8M
$-18.8M
Q4 24
$-23.8M
$-33.6M
Q3 24
$1.6M
$-19.0M
Q2 24
$2.4M
$-16.8M
FCF Margin
CATO
CATO
PRCT
PRCT
Q1 26
Q4 25
-8.3%
-15.9%
Q3 25
5.9%
-11.4%
Q2 25
1.7%
-22.5%
Q1 25
-5.0%
-27.2%
Q4 24
-16.3%
-49.2%
Q3 24
0.9%
-32.6%
Q2 24
1.4%
-31.4%
Capex Intensity
CATO
CATO
PRCT
PRCT
Q1 26
Q4 25
0.3%
2.4%
Q3 25
0.8%
3.4%
Q2 25
0.6%
3.5%
Q1 25
0.9%
2.7%
Q4 24
1.2%
1.7%
Q3 24
0.9%
0.4%
Q2 24
1.8%
2.0%
Cash Conversion
CATO
CATO
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.72×
Q2 25
1.17×
Q1 25
Q4 24
Q3 24
32.95×
Q2 24
0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CATO
CATO

Retail Segment$154.7M100%
Credit Card$5.3M3%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons